O r i g i n a l A r tic le
I NTRO D U C TIO N
Breast milk is the single best food source for infants. However, the breast milk of mothers on normal diets only contains 25-78 IU/L of vitamin D and is therefore insufficient as a source of vitamin D for infants. (1) The optimal blood level of 25-hydroxyvitamin D (25OHD) in newborns is as yet unknown. (1, 2) However, it is generally accepted that a serum 25OHD level of 11 ng/mL in newborns is sufficient to prevent rickets (2, 3) and that a serum 25OHD level of more than 30 ng/mL is necessary to control secondary hyperparathyroidism as well as increase calcium absorption. Serum 25OHD levels of more than 30 ng/mL are accepted as ideal, and 25OHD levels less than 20 ng/mL are considered deficient.
To provide adequate levels of vitamin D to newborns, the American Academy of Pediatrics (AAP) recommends universal oral vitamin D supplementation at 400 IU/day for all breastfeeding infants. (1) This dosage, believed by many experts as the minimal appropriate dose for infants, (2, 3) is generally thought to be sufficient to prevent rickets and vitamin D deficiency in neonates, although in certain situations, higher vitamin D supplementation may be necessary.
According to some studies, 25OHD concentrations in umbilical cord blood at the time of delivery ranges between 68% and 108% of maternal 25OHD levels, and therefore infants born to vitamin D-deficient mothers would have low reserves of vitamin D. (4, 5) In the present study, we aimed to determine whether the recommended dose of 400 IU/day of vitamin D for newborns was optimal for infants born to vitamin D-deficient mothers in Iran.
Vitamin D insufficiency is common among healthy pregnant women worldwide, especially in the Middle East. with low vitamin D levels may be more prone to unbalanced immune responses or diseases in the future. (6) (7) (8) (9) (10) In view of such studies, we attempted to determine the time needed to attain sufficient levels of serum 25OHD in vitamin D-deficient newborns on two different vitamin D supplementation regimens -infants receiving the recommended 400 IU/day within two weeks of life were categorised as being on standard-dose regimen (SDR), while those who received 30,000 IU/month as a single oral bolus were grouped as infants on high-dose regimen (HDR).
M E TH O DS
In a quasi-experimental clinical trial without randomisation, 
R E SU LT S
In total, 41 boys and 32 girls were included in our study, with supplementation and all infants achieved an ideal 25OHD level by four months (Fig. 3) .
Of the 48 infants in the SDR group, 5 were excluded from the analysis. Among the remaining 43 infants, 28 attained serum 25OHD level > 20 ng/mL within two months of standard-dose vitamin D3 supplementation, while 2 infants reached ideal levels within four months of supplementation. 
D I SCU S S IO N
We found that high-dose supplementation of vitamin D3
at birth was both a safe and effective means of supplying in the first month of life upon administration of the currently recommended doses for vitamin D supplementation. (12, 13) Some others have even recommended alternative doses in the range of 800-1,000 IU/day following birth, in order to attain acceptable levels of serum 25OHD. (2, 3, 12, 13) In our study, after four months of supplementation, the percentage of infants who were not deficient (i.e 25OHD level > 20 ng/mL) in Table I 
Greer, meanwhile, highlighted the need to establish the nonskeletal clinical implications of this period. in infants. (20, 21) In infants, the safe upper limit for serum 25OHD is accepted as serum level < 100 ng/mL. 
The present study had several limitations. We were unable to monitor sun exposure in our infants and mothers. As it is customary in Iran to prevent the exposure of infants to the sun in the early months of life, we assumed that sun exposure had limited effects in our cohort, especially during the first two months. Furthermore, mothers included in our study had 
